Evolution of the Average Target: Ryman Healthcare Limited

Evolution of the Target Price: Ryman Healthcare Limited

Changes in Analyst Recommendations: Ryman Healthcare Limited

e0623.pDiRQaIGRHIKiMSK4wI1ZZN165hrV7f9VnKfOnP_sU8.k2KhKMhEEzE9v4n8tFJCVvcgpcpbD_qQZRardz613TzAQtYe9mozAH3h9A~f1921dc4df6862606f6575a0509c7b94

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+51.8%
+9.6%
+21.64%
+25.06%
+14.85%
+18.6%
+13.77%
+21.83%
+33.88%
+10.84%
Average +22.19%
Weighted average by Cap. +17.41%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.080NZD
Average target price
3.158NZD
Spread / Average Target
+51.80%
High Price Target
3.700NZD
Spread / Highest target
+77.88%
Low Price Target
2.950NZD
Spread / Lowest Target
+41.83%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jarden Research
UBS
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.080NZD
Average target price
3.158NZD
Spread / Average Target
+51.80%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RYM Stock
  4. Consensus Ryman Healthcare Limited